Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-25-037620
Filing Date
2025-03-12
Accepted
2025-03-12 07:05:26
Documents
109
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K amrn-20241231.htm   iXBRL 10-K 4189096
2 EX-19.1 amrn-ex19_1.htm EX-19.1 63264
3 EX-19.2 amrn-ex19_2.htm EX-19.2 114529
4 EX-21.1 amrn-ex21_1.htm EX-21.1 20405
5 EX-23.1 amrn-ex23_1.htm EX-23.1 8485
6 EX-31.1 amrn-ex31_1.htm EX-31.1 16261
7 EX-31.2 amrn-ex31_2.htm EX-31.2 16567
8 EX-32.1 amrn-ex32_1.htm EX-32.1 12598
9 EX-97.1 amrn-ex97_1.htm EX-97.1 41382
10 GRAPHIC img153261572_0.jpg GRAPHIC 106009
11 GRAPHIC img153261572_1.jpg GRAPHIC 224875
  Complete submission text file 0000950170-25-037620.txt   18304203

Data Files

Seq Description Document Type Size
12 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT amrn-20241231.xsd EX-101.SCH 2037804
112 EXTRACTED XBRL INSTANCE DOCUMENT amrn-20241231_htm.xml XML 3640267
Mailing Address SPACES SOUTH DOCKLANDS, BLOCK C 77 SIR JOHN ROGERSON'S QUAY DUBLIN 2 L2 D02 VK60
Business Address SPACES SOUTH DOCKLANDS, BLOCK C 77 SIR JOHN ROGERSON'S QUAY DUBLIN 2 L2 D02 VK60 353 1 6699 020
AMARIN CORP PLC\UK (Filer) CIK: 0000897448 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-21392 | Film No.: 25729972
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)